NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints
In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000
DCBD Board Votes down, Then Approves Organ Systems PA
NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says
Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Galleri MCD vote: What FDA asked its advisors to ignore
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









